Zhuang Liu Selected Research

Indicators and Reagents (Reagents)

1/2024	External validation of the FAMISH predicting score for early gastric cancer with endoscopic submucosal dissection.
1/2021	Bio-inspired dual-functional phospholipid-poly(acrylic acid) brushes grafted porous poly(vinyl alcohol) beads for selective adsorption of low-density lipoprotein.
1/2020	Analyses of DNA Methylation Involved in the Activation of Nuclear Karyopherin Alpha 2 Leading to Identify the Progression and Prognostic Significance Across Human Breast Cancer.
6/2015	Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes.
1/2014	Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on CuS nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhuang Liu Research Topics

Disease

325	Neoplasms (Cancer) 05/2024 - 12/2004
38	Hypoxia (Hypoxemia) 11/2023 - 10/2015
32	Neoplasm Metastasis (Metastasis) 11/2023 - 08/2014
19	Breast Neoplasms (Breast Cancer) 04/2022 - 02/2008
13	Inflammation (Inflammations) 02/2024 - 01/2017
11	Melanoma (Melanoma, Malignant) 01/2024 - 01/2019
11	Hyperthermia 01/2023 - 10/2017
8	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2018
8	Infections 01/2024 - 03/2002
8	Wounds and Injuries (Trauma) 01/2024 - 11/2014
7	Bites and Stings (Sting) 01/2024 - 02/2021
6	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2017
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
4	Circulating Neoplastic Cells 05/2024 - 06/2015
4	Bacterial Infections (Bacterial Infection) 02/2024 - 01/2017
4	COVID-19 01/2023 - 01/2021
4	Necrosis 01/2023 - 12/2021
4	Hyperlipidemias (Hyperlipidemia) 08/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

30	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
30	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2017
30	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023 - 09/2011
27	PolymersIBA 12/2023 - 05/2011
27	Oxygen (Dioxygen)IBA 01/2023 - 07/2015
20	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 08/2016
20	Therapeutic UsesIBA 07/2023 - 11/2013
18	Photosensitizing Agents (Photosensitizers)IBA 10/2023 - 09/2011
17	HydrogelsIBA 01/2024 - 08/2015
15	AntigensIBA 09/2023 - 05/2014
15	AlbuminsIBA 02/2023 - 11/2014
14	Radioisotopes (Radionuclides)IBA 01/2021 - 10/2015
13	MetalsIBA 01/2024 - 03/2014
13	CytokinesIBA 11/2023 - 07/2015
13	Liposomes (Liposome)IBA 11/2023 - 01/2017
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2007
12	GraphiteIBA 01/2017 - 08/2008
11	VaccinesIBA 11/2023 - 06/2015
11	phytochlorinIBA 10/2023 - 09/2011
11	EnzymesIBA 10/2023 - 01/2017
11	Cancer VaccinesIBA 04/2023 - 01/2018
11	ProdrugsIBA 10/2022 - 08/2008
11	LigandsIBA 01/2022 - 10/2008
11	Coloring Agents (Dyes)IBA 11/2020 - 12/2011
11	Carbon Nanotubes (Carbon Nanotube)IBA 01/2016 - 08/2008
10	Biocompatible Materials (Biomaterials)IBA 05/2024 - 10/2018
10	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2024 - 03/2012
9	AntibodiesIBA 01/2024 - 02/2008
9	ChitosanIBA 01/2024 - 01/2016
9	InterferonsIBA 01/2024 - 01/2011
9	CatalaseIBA 12/2023 - 09/2017
9	IronIBA 04/2023 - 04/2015
9	NanovaccinesIBA 01/2023 - 01/2018
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2002
9	Contrast MediaIBA 03/2022 - 06/2010
8	OxidesIBA 01/2024 - 08/2008
8	LipidsIBA 01/2024 - 10/2017
8	IonsIBA 01/2024 - 11/2015
8	Glutathione (Reduced Glutathione)IBA 01/2024 - 01/2019
8	Peptides (Polypeptides)IBA 01/2022 - 08/2002
7	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2002
7	FluorocarbonsIBA 01/2024 - 04/2016
7	Chelating AgentsIBA 11/2018 - 05/2015
7	graphene oxideIBA 10/2016 - 03/2012
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 06/2011
6	AntioxidantsIBA 12/2023 - 07/2015
6	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2023 - 01/2020
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 06/2019
6	MXeneIBA 03/2022 - 12/2017
6	Singlet OxygenIBA 01/2020 - 09/2011
6	ferric oxide (iron oxide)IBA 01/2018 - 08/2013
5	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 04/2016
5	polydopamineIBA 01/2024 - 01/2016
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 10/2019
5	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2014
5	Ethylene Glycol (Monoethylene Glycol)IBA 11/2023 - 08/2007
5	tetracarboxyphenylporphineIBA 11/2023 - 08/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
5	PlatinumIBA 01/2022 - 08/2008
5	Folic Acid (Vitamin M)FDA LinkGeneric 06/2021 - 08/2008
5	Human Serum Albumin FDA LinkGeneric 06/2019 - 09/2015
5	Drug CarriersIBA 05/2018 - 08/2013
4	HydrogenIBA 11/2023 - 01/2020
4	Programmed Cell Death 1 ReceptorIBA 11/2023 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2008
4	CollagenIBA 01/2023 - 12/2018
4	oxidized low density lipoproteinIBA 08/2022 - 01/2021
4	LDL Lipoproteins (beta Lipoproteins)IBA 08/2022 - 01/2021

Therapy/Procedure

177	Therapeutics 02/2024 - 08/2008
68	Precision Medicine 01/2024 - 10/2011
59	Immunotherapy 01/2024 - 06/2015
52	Photothermal Therapy 02/2022 - 09/2010
49	Radiotherapy 11/2023 - 10/2015
48	Intravenous Injections 01/2024 - 03/2012
44	Drug Therapy (Chemotherapy) 01/2024 - 10/2013
35	Photochemotherapy (Photodynamic Therapy) 10/2023 - 09/2011
27	Lasers (Laser) 02/2024 - 09/2010
8	Microspheres (Microsphere) 01/2024 - 10/2021
6	Intravenous Administration 01/2023 - 06/2010
5	Hemoperfusion 02/2024 - 12/2021
5	Intravesical Administration 01/2022 - 01/2019
5	Phototherapy (Light Therapy) 04/2020 - 11/2014